Pages that link to "Q89653947"
Jump to navigation
Jump to search
The following pages link to David L Thomas (Q89653947):
Displaying 50 items.
- A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus (Q24307721) (← links)
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virus (Q24596340) (← links)
- Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus (Q24596652) (← links)
- An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases (Q24632766) (← links)
- High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan (Q24673331) (← links)
- Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees (Q27469342) (← links)
- Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy (Q27469352) (← links)
- Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single-and double-stranded DNAs (Q27469409) (← links)
- Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees (Q27469647) (← links)
- Detection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCV (Q27469764) (← links)
- Human Immunodeficiency Virus Seroconversion and Evolution of the Hepatitis C Virus Quasispecies (Q27469782) (← links)
- HLA-Cw*04 and hepatitis C virus persistence (Q27472874) (← links)
- Progression of Fibrosis during Chronic Hepatitis C Is Associated with Rapid Virus Evolution (Q27480339) (← links)
- Factors Affecting Serum Concentrations of Hepatitis C Virus (HCV) RNA in HCV Genotype 1-Infected Patients with Chronic Hepatitis (Q27480999) (← links)
- Divergent and convergent evolution after a common-source outbreak of hepatitis C virus (Q27485216) (← links)
- Cellular immune selection with hepatitis C virus persistence in humans (Q27485219) (← links)
- Immunoglobulin allotypes influence IgG antibody responses to hepatitis C virus envelope proteins E1 and E2 (Q27485929) (← links)
- Genetic Markers of IgG Influence the Outcome of Infection with Hepatitis C Virus (Q27488362) (← links)
- Maternal Neutralizing Antibody and Transmission of Hepatitis C Virus to Infants (Q27490404) (← links)
- Hepatitis C in the HIV-Infected Person (Q28206126) (← links)
- Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis (Q28362291) (← links)
- Human immunodeficiency virus and liver disease forum 2010: conference proceedings (Q28674930) (← links)
- Diagnosis, management, and treatment of hepatitis C: an update (Q29619682) (← links)
- Diagnosis, management, and treatment of hepatitis C (Q29620656) (← links)
- Resurrecting the triple threat: academic social responsibility in the context of global health research (Q30376172) (← links)
- Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts (Q30590832) (← links)
- Barriers to Hepatitis C Virus (HCV) Treatment Initiation in Patients With Human Immunodeficiency Virus/HCV Coinfection: Lessons From the Interferon Era. (Q33629538) (← links)
- HIV/HCV Co-infection, Liver Disease Progression, and Age-Related IGF-1 Decline (Q33657640) (← links)
- Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses (Q33707246) (← links)
- Direct-acting antiviral agents and the path to interferon independence (Q33727347) (← links)
- Understanding the natural history of chronic HBV and HCV infections (Q33817582) (← links)
- Hepatitis E: an emerging infectious disease (Q33842661) (← links)
- Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection (Q33853655) (← links)
- Class II HLA alleles and hepatitis B virus persistence in African Americans (Q33854434) (← links)
- Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome (Q33870620) (← links)
- Chronic viral hepatitis and the human genome (Q33873340) (← links)
- Mannose binding lectin genotypes influence recovery from hepatitis B virus infection (Q33883928) (← links)
- Determinants of the quantity of hepatitis C virus RNA. (Q33893570) (← links)
- Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus (Q33894507) (← links)
- Progression of Biopsy-Measured Liver Fibrosis in Untreated Patients with Hepatitis C Infection: Non-Markov Multistate Model Analysis (Q33921088) (← links)
- Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection (Q33929089) (← links)
- Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients (Q33946635) (← links)
- Screening for hepatitis C virus in human immunodeficiency virus-infected individuals (Q33965308) (← links)
- The natural history of hepatitis C virus infection: host, viral, and environmental factors (Q33974693) (← links)
- Prospective evaluation of community-acquired acute-phase hepatitis C virus infection (Q33986385) (← links)
- Humoral immune response in acute hepatitis C virus infection (Q33989160) (← links)
- High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities (Q33989662) (← links)
- Reciprocal interaction of human immunodeficiency virus and hepatitis C virus infections (Q33999381) (← links)
- HTLV-II and bacterial infections among injection drug users (Q34062908) (← links)
- Protection against persistence of hepatitis C. (Q34126534) (← links)